Recent Advances in Glycobiology

For the most part glycan’s are significant components of various bio remedial specialists, clashing from normal items to particles dependent on different reasonable structures to recombinant glycoproteins and Glycoconjugate.
The glycan parts of these operators can be significant fundamentals of their natural movement and helpful capacity.
On-going licensing of novel therapeutics commonly requires clarifications of the course of action of issue in the guaranteed particle for endorsement. Different prevailing developments can be found in the territories of imaging, structure expectation innovations and progression of cross breed methods to recognize the structure and job of starches and proteins

  • Tissue regeneration
  • Cancer stem cells
  • Bone marrow transplantation
  • Somatic cell therapy
  • Stem cell technologies

Related Conference of Recent Advances in Glycobiology

March 15-16, 2021

12th Tissue Repair and Regeneration Congress

Dubai, UAE
July 30-30, 2021

Glycobiology Biochem Conference 2021

London, UK
September 06-06, 2021

27th Asia Pacific Biotechnology Congress

London, UK
September 10-10, 2021

5th International Conference on Protein Engineering

London, UK
September 13-14, 2021

17th World Congress on Structural Biology

Prague, Czech Republic
September 27-28, 2021

25th European Biotechnology Congress

Dublin, Ireland
November 08-09, 2021

23rd Global Biotechnology Congress

Singapore City, Singapore
November 18-19, 2021

25th World Congress on Pharmaceutical Biotechnology

Barcelona, Spain
December 01-02, 2021

18th International Conference on Metabolomics and Proteomics

Frankfurt, Germany
December 08-09, 2021

World Congress on Biosensors and Bioelectronics

London, UK
February 25-26, 2022

International Conference on Biotechnology

Singapore, Singapore
August 22-23, 2021

15thInternational Conference on Proteomics, Genomics & Bioinformatics

Singapore City, Singapore

Recent Advances in Glycobiology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in